Since copper is a trace mineral required in minimal doses, excess intake can cause nausea, gastrointestinal issues, and other health problems
Choose Retatrutide If: Maximum weight loss is the primary goal Previous GLP-1 agonists produced significant nausea (GIP component may help) No specific liver health concerns requiring treatment Tolerance for slightly higher GI side effects during titration Response to dual agonists (like tirzepatide) has been positive Choose Survodutide If: Liver health concerns exist (fatty liver, MASH, elevated liver enzymes) Moderate weight loss goals rather than maximum efficacy priority Interest in potential cardiovascular outcome benefits (CVOT data pending) Preference for a compound with FDA Breakthrough Therapy designation Plans to potentially transition to approved medication once available For most people focused primarily on weight loss, Retatrutide presents the stronger option based on available data
Minimize your consumption of processed foods and fast food
Topical copper peptides versus minoxidil Minoxidil is an established drug with labelled indications and human clinical evidence
The MB System launched on March 15, 2025, for LifeVantage Consultants in multiple countries, with broader customer access starting April 25
By the second or third week, benefits often become more noticeable